Info-congres. Insulinotherapie pour prevenir le diabete de type 1 chez des sujets apparentes a haut risque: resultats negatifs du "Diabetes Prevention Trial-Type 1".
Scheen, André; Philips, Jean-Christophe
2001 • In Revue Médicale de Liège, 56 (7), p. 536-8
[en] The results of the American multicentre "Diabetes Prevention Trial-Type 1" were presented by J. Skyler during the last congress of the American Diabetes Association in Philadelphia on June 23, 2001. The prophylactic subcutaneous administration of low-dose insulin was not able to prevent the development of type 1 diabetes nor to preserve residual insulin secretion in young relatives at very high-risk of diabetes (> 50% in the next 5 years), selected upon genetic, immunological and metabolic criteria.
Disciplines :
Endocrinology, metabolism & nutrition
Author, co-author :
Scheen, André ; Université de Liège - ULiège > Département des sciences cliniques > Diabétologie, nutrition et maladie métaboliques - Médecine interne générale
Philips, Jean-Christophe ; Centre Hospitalier Universitaire de Liège - CHU > Diabétologie,nutrition, maladies métaboliques
Language :
French
Title :
Info-congres. Insulinotherapie pour prevenir le diabete de type 1 chez des sujets apparentes a haut risque: resultats negatifs du "Diabetes Prevention Trial-Type 1".
Alternative titles :
[en] Info-congress. Insulin therapy for preventing type 1 diabetes in high-risk relatives: negative results of the "Diabetes Prevention Trial-Type 1"
Scheen, A.J., Prévention du diabète de type 2 chez le sujet avec excès pondéral et diminution de la tolérance au glucose: Efficacité des mesures hygiéno-diététiques (2001) Rev Med Liège, 56, pp. 463-465
Geenen, V., Le diabète insulinodépendant (1996) Rev Med Liège, 51, pp. 684-694
Philips, J.C., Letiexhe, M.R., Paquot, N., Comment j'explore ... Un patient avec diabète de type 1 inaugural ou à risque de développer la maladie (1997) Rev Med Liège, 52, pp. 363-366
Bingley, P.J., Bonifacio, E., Ziegler, A.-G., Proposed guidelines on screening for risk of type 1 diabetes (2001) Diabetes Care, 24, p. 398
Simone, E.A., Wegmann, D.R., Eisenbarth, G.S., Immunologic "vaccination" for the prevention of autoimmune diabetes (type 1A) (1999) Diabetes Care, 22 (SUPPL. 2), pp. 7B-15B
Schatz, D.A., Bingley, P.J., Update on major trials for the prevention of type 1 diabetes mellitus: The American Diabetes Prevention Program (DPT-1) and the European Nicotinamide Diabetes Intervention Trial (ENDIT) (2001) J Pediatr Endocrinol Metab, 14 (SUPPL. 1), pp. 619-622
Prevention of type 1 diabetes mellitus (2000) Diabetes Care, 23 (SUPPL. 1), pp. S108
Silverstein, J.H., Rosenbloom, A.L., New developments in type 1 (insulin-dependent) diabetes (2000) Clin Pediatr, 39, pp. 257-266
Rosenbloom, A., Schatz, D.A., Krischer, J.P., Therapeutic controversy. Prevention and treatment of diabetes in children (2000) J Clin Endocrinol Metab, 85, pp. 494-522
Keller, R.J., Eisenbarth, G.S., Jackson, R.A., Insulin prophylaxis in individuals at high risk of type 1 diabetes (1993) Lancet, 341, pp. 927-928
Greenbaum, C.J., Schatz, D.A., Cuthbertson, D., Islet cell antibody-positive relatives with human leukocyte antigen DQA1*0102, DQB1*0602: Identification by the Diabetes Prevention Trial-Type 1 (2000) J Clin Endocrinol Metab, 85, pp. 1255-1260
Luyckx, F., Delcour, S., Philips, J.C., Scheen, A.J., Le dosage des auto-anticorps anti-GAD et anti-IA2: Une aide au diagnostic précoce du diabète de type 1 (2000) Rev Med Liège, 55, pp. 169-175
Greenbaum, C.J., Cuthbertson, D., Krisher, J.P., Type 1 diabetes manifested solely by 2-h oral glucose tolerance test criteria (2001) Diabetes, 50, pp. 470-476. , Disease Prevention Trial of Type 1 Diabetes Study Group
Chase, H.P., Cuthbertson, D.D., Dolan, L.M., First-phase insulin release during the intravenous glucose tolerance test as a risk factor for type 1 diabetes (2001) J Pediatr, 138, pp. 244-249
Chaillous, L., Lefèvre, H., Thivolet, Ch., Oral insulin administration and residual B-cell function in recent-onset type 1 diabetes: A multicentre randomised controlled trial (2000) Lancet, 356, pp. 545-549